Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
H&O Biosis Co. Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by 1 distinct examiner within 1 distinct art unit. The company's active intellectual property efforts are currently focused on a single application in this specialized field, indicating a concentrated prosecution strategy.
The busiest examiner for this portfolio is SPAINE, ROBERT FRANKLIN, who is responsible for the 1 pending office action. Because there is only one examiner and one art unit, the prosecution outcome is entirely dependent on this single interaction. Practitioners should focus on the specific standards of the Biotechnology & Pharmaceuticals art unit as applied by this examiner, as there are no other active cases to provide alternative examination paths for the company's current filings.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPAINE, ROBERT FRANKLIN | 1 | 75.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18710710 | PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTION OR TREATMENT OF CANCER COMPRISING MIXED HERBAL EXTRACT | SPAINE, ROBERT FRANKLIN | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18710710 | PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTION OR TREATMENT OF CANCER COMPRISING MIXED HERBAL EXTRACT | SPAINE, ROBERT FRANKLIN | 1655 | §102§103§112 | Non-Final OA | — | Pending | May 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialH&O Biosis Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Robert Franklin Spaine has the most, with 1 of H&O Biosis Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
